Results 151 to 160 of about 101,346 (400)

Pediatric Feeding Disorder: Consensus Definition and Conceptual Framework [PDF]

, 2019
Pediatric feeding disorders (PFDs) lack a universally accepted definition. Feeding disorders require comprehensive assessment and treatment of 4 closely related, complementary domains (medical, psychosocial, and feeding skill-based systems and associated
Browne, Joe, Cohen, Sherri S., de Camargo, Olaf Kraus, Delaney, Amy, Dodrill, Pamela, Feuling, Mary B., Gisel, Erika, Goday, Praveen S., Huh, Susanna Y., Kenzer, Amy, Kessler, Daniel B., Lukens, Colleen T., Noel, Richard J., Phalen, James A., Silverman, Alan   +14 more
core   +1 more source

SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial

Allergy, EarlyView.
Phase III trial investigating the efficacy and safety of SQ HDM SLIT‐tablet in children (5–17 years) with inadequately controlled HDM allergic asthma. Novel paediatric data showing that the safety profile of SQ HDM SLIT‐tablet is similar to that established in adults.
Graham Roberts, Jocelyne Just, Hendrik Nolte, Ole Holm Hels, Andrzej Emeryk, Carmen Vidal   +5 more
wiley   +1 more source

From pill to pain: Alendronate‐induced esophageal injury—A case report and review

JGH Open
Background Alendronate is used to treat Paget's bone disease, glucocorticoid‐induced osteoporosis, and postmenopausal osteoporosis because it suppresses osteoclast activity to stop bone resorption.
Zhen Fan, Hayat Khizar, Jinjiao Lu, Anhua Wang, Tong Xun, Xiao Zhang, Hongfeng Zhao   +6 more
doaj   +1 more source

Independent test of a model to predict severe acute esophagitis [PDF]

, 2017
Bradley, Jeffrey D, Deasy, Joseph O, Huang, Ellen X, Molotievschi, Alerson, Oh, Jung Hun, Robinson, Clifford G   +5 more
core   +2 more sources

Drug‐Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life‐threatening complications. Drug‐induced ocular adverse reactions are generally classified into two primary categories: toxic reactions ...
Andrea Leonardi, Banu Bozkurt, Diana Silva, Charlotte G. Mortz, Christophe Baudouin, Marina Atanaskovic‐Markovic, Vibha Sharma, Serge Doan, Shweta Agarwal, Daniel Pérez‐Formigo, Maria Joao Vasconcelos, Francoise‐Brignole Baudouin, Gonzalo Chorzepa, Jean‐Luc Fauquert, Virginia Calder, Pascal Demoly, Luis Delgado   +16 more
wiley   +1 more source

Antimicrobial prescribing guidelines for horses in Australia

Australian Veterinary Journal, EarlyView.
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt, K Thomas, S Page, J Norris, G Browning, C El Hage, A Stewart, J Gilkerson, G Muscatello, D Verwilghen, G van Galen, J Bauquier, R Cuming, B Reynolds, C Whittaker, E Wilkes, J Clulow, C Burden, L Begg   +18 more
wiley   +1 more source

Diagnosis and treatment of eosinophilic esophagitis.

Journal of Allergy and Clinical Immunology, 2020
N. Gonsalves, S. Aceves
semanticscholar   +1 more source

Severe Eosinophilic Endometritis Following Diagnostic Curettage [PDF]

, 2010
Severe Eosinophilic Endometritis appears after injury from a preoperative diagnostic procedure. It is an unusual and distinctive inflammatory uterine disease process, in response to eosinophil chemotactic substances.
Desai, SR, Shinagare, SA
core  

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

The Etiology and Treatment of Peptic Esophagitis

, 1956
Frederick S. Cross, Earle B. Kay
openalex   +2 more sources